Technology | September 28, 2010

Smartphone App Helps Physicians Assess the Need for Radionuclide Imaging

September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by using a new smartphone app. The app, which is available for free on iPhone, BlackBerry and Android phones, gives physicians access to published criteria used to assess the need for RNI. The "Appropriate Use Criteria (AUC) for Cardiac Radionuclide Imaging" app, by Astellas, describes 67 individual patient indications, eight indication categories and five algorithms. All indications were adapted from the AUC published in 2009 in Circulation. The app guides physicians step by step through the criteria to evaluate patient history, clinical factors, and other important information to receive an instant appropriate use score for RNI. By entering information, physicians will receive a rating on a scale of 1-9 suggesting if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3) for RNI. Ratings can be viewed either by indication/category or patient algorithm. "Astellas recognizes physicians are increasingly using smartphones and apps in the healthcare setting to access information," said Robert C. Hendel, M.D., FACC, FAHA, FASNC, and chair of the Cardiac Radionuclide Imaging Writing Group that developed the 2009 AUC for RNI. "We partnered with them to develop this accurate, timely assessment tool for use on smartphones and hope this app will promote awareness and use of the AUC for RNI published in 2009." According to the annual "Taking the Pulse" study of physicians and healthcare technology released in April 2010, 72 percent of physicians use smartphones personally and professionally. That number is expected to jump to 81 percent in 2012. For more information: www.astellasapps.com


Related Content

News | Cardiac Imaging

Aug. 12, 2026 — Salus Scientific has launched its Clinical Insights Series, a new publication platform designed to share ...

Home August 17, 2026
Home
News | Cardiac Imaging

Aug. 12, 2026 — Ventripoint Diagnostics is expanding subscription-based access to its VMS+ 4.0, its FDA-cleared platform ...

Home August 14, 2026
Home
News | Cardiac Imaging

August 4, 2026 - Epsilon Imaging and ASCEND Cardiovascular have announced a strategic non-exclusive partnership designed ...

Home August 13, 2026
Home
Feature | Cardiac Imaging | John Memarian

The last few decades have been marked by rapid advances in cardiovascular medicine, particularly in areas like imaging ...

Home August 06, 2026
Home
News | Cardiac Imaging

August 3, 2026 — Despite improvements in technology and awareness, work-related musculoskeletal disorders (WRMSDs) ...

Home August 03, 2026
Home
News | Cardiac Imaging

June 9 2026 — With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray ...

Home June 12, 2026
Home
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Home May 21, 2026
Home
News | Cardiac Imaging

May 1, 2026 — On May 14, Cleerly and interventional cardiologist Neerav Sheth, MD, will present a free webinar on ...

Home May 12, 2026
Home
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Home April 29, 2026
Home
News | Cardiac Imaging

April 23, 2026 — Royal Philips has launched the next-generation Bridge Plus Occlusion Balloon, designed to help ...

Home April 23, 2026
Home
Subscribe Now